课题基金 / 基金详情

Molecular analysis of malignant lymphoma-related oncogenes and its clinical application for diagnosis and treatment.

Molecular analysis of malignant lymphoma-related oncogenes and its clinical application for diagnosis and treatment.
恶性淋巴瘤相关癌基因的分子分析及其临床诊断和治疗应用。
批准号:
15591034
负责人:
HOSOKAWA Yoshitaka
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

HOSOKAWA Yoshitaka的其他基金

相似基金

相关文献

中文摘要
翻译
1) API2-MALT1。t(11;18)(q21;q21)是粘膜相关淋巴组织(MALT)型淋巴瘤的特征性染色体易位,这种易位导致API2(凋亡抑制剂2,也称为c-IAP2)-MALT1(粘膜相关淋巴瘤易位基因1)的嵌合转录。为了鉴定与API2-MALT1嵌合蛋白结合的蛋白,我们采用了共免疫沉淀和SDS PAGE分析,然后采用液相色谱-电喷雾电离串联质谱法。结果,Smac、Htra2和TRAF2被鉴定为api2 - malt1结合蛋白。免疫沉淀分析表明,异位表达的API2-MALT1蛋白确实与这些内源性蛋白结合。此外,API2-MALT1蛋白显著抑制smac促进的紫外线照射HeLa细胞凋亡。这些数据强烈提示API2-MALT1可以通过抑制smac介导的凋亡途径(2)BCL6,至少在一定程度上阻断细胞凋亡。BCL-6/LAZ3基因编码锌指转录抑制因子,位于非霍奇金淋巴瘤(nhl)中最常见的3q27相关翻译的断点。为了研究细胞反应和与BCL-6信号通路相关的靶基因,我们建立了Ba/F3前b细胞,该细胞携带在乳糖操纵子控制下可诱导的人BCL-6转基因。利用cDNAarray杂交技术,我们发现诱导的BCL-6蛋白可以下调cyclin A2基因的表达。趋化因子受体CXCR4和胰岛素样生长因子结合蛋白-4(IGFBP-4)在Ba/F3细胞中的表达。Northern blot分析证实,这些基因的表达确实被诱导的BCL-6蛋白下调,但表达方式有所不同。诱导的BCL-6蛋白也能抑制Ba/F3细胞的增殖。这些发现强烈提示,在b淋巴细胞分化过程中,三个关键基因cyclin A2、CXCR4和IGFBP-4可能在BCL-6信号通路的下游发挥作用。少
英文摘要
1)API2-MALT1. t(11;18)(q21;q21) is a characteristic chromosomal translocation in mucosa-associated lymphoid tissue(MALT) type lymphoma, and this translocation results in chimeric transcript of API2(APoptosis Inhibitor 2,also known as c-IAP2)-MALT1(Mucosa-Associated Lymphoma Translocation gene 1). To identify proteins that bind API2-MALT1 chimeric protein, we employed coimmunoprecipitation and SDS PAGE analysis, followed by liquid chromatography-electrospray ionization tandem mass spectrometry. As a result, Smac, Htra2,and TRAF2 were identified as API2-MALT1-binding proteins. Immunoprecipitation analysis demonstrated that ectopically expressed API2-MALT1 protein indeed binds to these endogeneous proteins. Furthermore, API2-MALT1 protein significantly inhibited Smac-promoted apoptosis in UV irradiated HeLa cells. These data strongly suggest that API2-MALT1 can block apoptosis, at least in part, by inhibiting Smac-mediated apoptotic pathway.2)BCL6. The BCL-6/LAZ3 gene encodes a zinc-finge … More r transcriptional represser and is located at the breakpoint of the 3q27-associated translations that occur most frequently in non-Hodgkin's lymphomas (NHLs To examine cell responses and target genes related to the BCL-6 signaling pathway, we established Ba/F3 pro-B cells carrrying a human BCL-6 transgene that is inducible under control of the lactose operon. Using a cDNAarray hybridization technique, we found that the induced BCL-6 protein can downregulate the expressions of the genes, cyclin A2. chemokine receptor CXCR4,and insulin-like growth factor binding protein-4(IGFBP-4) in the Ba/F3 cells. Northern blot analysis established that the expressions of these genes were indeed downregulated by the induced BCL-6 protein but in a somewhat different manner. The induced BCL-6 protein also inhibited cell proliferation of Ba/F3 cells. These findings strongly suggest that three key genes, namely cyclin A2,CXCR4 and IGFBP-4 may play a role in the downstream of the BCL-6 signaling pathway during B-lymphoid differentiation. Less
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
Tagawa H.et al.: "MASL1,a candidate oncogene found in amplication at 8p23.1,is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8."Oncogene. in press.
Takawa H.等人:“MASL1,一种在 8p23.1 扩增中发现的候选癌基因,在免疫母细胞 B 细胞淋巴瘤细胞系 OCI-LY8 中易位。”癌基因。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Izumiyama K et al.: "Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18)(q21;q21) MALT lymphoma."Oncogene. 22. 8085-8092 (2003)
Izumiyama K 等人:“t(11;18)(q21;q21) MALT 淋巴瘤中涉及的 API2-MALT1 嵌合蛋白的稳定性和亚细胞定位。”癌基因。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Suguro-Katayama M et al.: "Heterogeneous copy number of API2-MALT1 chimeric transcripts in mucosa-associated lymphoid tissue lymphoma."Leukemia. 17. 2508-2512 (2003)
Suguro-Katayama M 等人:“粘膜相关淋巴组织淋巴瘤中 API2-MALT1 嵌合转录物的异质拷贝数。”白血病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Stability and subcellular localization of API2-MAIT1 chimeric protein involved in t(11;18)(q21;q21) MALT lymphoma
t(11;18)(q21;q21) MALT 淋巴瘤中 API2-MAIT1 嵌合蛋白的稳定性和亚细胞定位
DOI: --
发表时间: 2003
期刊: Oncogene 22
影响因子: --
作者: [Hosokawa Y, Seto M., Izumiyama K et al.]
通讯作者: Izumiyama K et al.
共 16 条
    Basic study of the bioactive substances of a skin of citrus fruits for periodontal disease treatment
    • 批准号:
      19K10151
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2019
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    Analysis of leukocyte infiltration mechanism to participate in inflammatory bone resorption in periodontal lesion
    • 批准号:
      16K11834
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2016
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    Analysis of Th17 cells migration and activation in periodontally diseased tissues
    • 批准号:
      25463219
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2013
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    Analysis of Th17 cells migration inperiodontally diseased tissues.
    • 批准号:
      23792479
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2011
    • 负责人:
      HOSOKAWA Yoshitaka
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: